AHA GUIDELINES Bundle (free trial)

Diagnosis and Treatment ����ICD therapy may be considered in patients: ������ with nonischemic heart disease who have an LVEF of ���35% and who are in NYHA functional class I. (IIb-C) ������ with long-QT syndrome and risk factors for SCD. (IIb-B) ������ with syncope and advanced structural heart disease in whom thorough invasive and noninvasive investigations have failed to define a cause. (IIb-C) ������ with a familial cardiomyopathy associated with sudden death. (IIb-C) ������ with LV noncompaction. (IIb-C) ����ICD therapy is NOT indicated: ������ for patients who do not have a reasonable expectation of survival with an acceptable functional status for ���1 year, even if they meet ICD implantation criteria specified in the Class I, IIa, and IIb recommendations above. (III-C) ������ for patients with incessant VT or VF. (III-C) ������ for patients with significant psychiatric illnesses that may be aggravated by device implantation or that may preclude systematic follow-up. (III-C) ������ for NYHA class IV patients with drug-refractory congestive HF who are not candidates for cardiac transplantation or CRT defibrillator (CRT-D). (III-C) ������ syncope of undetermined cause in a patient without inducible ventricular tachyarrhythmias and without structural heart disease. (III-C) ������ when VF or VT is amenable to surgical or catheter ablation (eg, atrial arrhythmias associated with the Wolff-Parkinson-White syndrome, RV or LV outflow tract VT, idiopathic VT, or fascicular VT in the absence of structural heart disease). (III-C) ������ for patients with ventricular tachyarrhythmias due to a completely reversible disorder in the absence of structural heart disease (eg, electrolyte imbalance, drugs, or trauma). (III-B) Pediatric Patients and Patients With Congenital Heart Disease Note: All Class III recommendations found in Section 3 of the full text guidelines, ���Indications for Implantable Cardioverter-Defibrillator Therapy,��� apply to pediatric patients and patients with congenital heart disease. ICD implantation is not indicated in these patient populations. (III-C) ����ICD implantation is indicated: ������ in the survivor of cardiac arrest after evaluation to define the cause of the event and to exclude any reversible causes. (I-B) ������ for patients with symptomatic sustained VT in association with congenital heart disease who have undergone hemodynamic and electrophysiological evaluation. (I-C) Catheter ablation or surgical repair may offer possible alternatives in carefully selected patients. ����ICD implantation is reasonable: ������ for patients with congenital heart disease with recurrent syncope of undetermined origin in the presence of either ventricular dysfunction or inducible ventricular arrhythmias at electrophysiological study. (IIa-B) ����ICD implantation may be considered: ������ for patients with recurrent syncope associated with complex congenital heart disease and advanced systemic ventricular dysfunction when thorough invasive and noninvasive investigations have failed to define a cause. (IIb-C) 12

• Cover